Real world experience with cladribine tablets for multiple sclerosis at four academic multiple sclerosis centers

This publication has 18 references indexed in Scilit:

• Real-world treatment patterns and effectiveness of cladribine tablets in patients with relapsing forms of multiple sclerosis in the United States
  Multiple Sclerosis and Related Disorders, 2023
• Real-world use of cladribine tablets (completion rates and treatment persistence) in patients with multiple sclerosis in England: The CLARENCE study
  Multiple Sclerosis and Related Disorders, 2023
• Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis
  Neurologic Clinics, 2023
• Cladribine tablets in people with relapsing multiple sclerosis: A real-world multicentric study from southeast European MS centers
  Journal of Neuroimmunology, 2023
• Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review
  Neurology and Therapy, 2022
• Validating Neuro-QoL short forms and targeted scales with people who have multiple sclerosis
  Multiple Sclerosis Journal, 2015
• Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing
  Quality of Life Research, 2011
• Cladribine
  Clinical Neuropharmacology, 2011
• A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
  New England Journal of Medicine, 2010
• Factors related to agreement between self-reported and conventional Expanded Disability Status Scale (EDSS) scores
  Multiple Sclerosis Journal, 2001